Nissay Asset Management Corp Japan Purchases 2,678 Shares of UnitedHealth Group Incorporated $UNH

Nissay Asset Management Corp Japan grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.3% during the second quarter, HoldingsChannel reports. The institutional investor owned 120,615 shares of the healthcare conglomerate’s stock after buying an additional 2,678 shares during the period. Nissay Asset Management Corp Japan’s holdings in UnitedHealth Group were worth $50,131,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of UNH. Sarver Vrooman Wealth Advisors bought a new stake in shares of UnitedHealth Group during the fourth quarter worth $25,000. Aberdeen Wealth Management LLC purchased a new position in UnitedHealth Group in the 2nd quarter worth about $31,000. Anfield Capital Management LLC boosted its position in UnitedHealth Group by 220.0% in the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after buying an additional 55 shares during the period. Nalls Sherbakoff Group LLC bought a new position in UnitedHealth Group in the 4th quarter worth about $27,000. Finally, Lifetime Wealth Management P.C. bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $29,000. Institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several research analysts have commented on UNH shares. Barclays raised their price objective on UnitedHealth Group from $429.00 to $441.00 and gave the stock an “overweight” rating in a report on Monday, July 20th. Erste Group Bank lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of UnitedHealth Group in a research note on Thursday, June 11th. Robert W. Baird upgraded shares of UnitedHealth Group from an “underperform” rating to a “neutral” rating and boosted their price target for the company from $287.00 to $453.00 in a report on Thursday, July 16th. Finally, Morgan Stanley increased their price objective on shares of UnitedHealth Group from $468.00 to $529.00 and gave the company an “overweight” rating in a research note on Friday, July 17th. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average price target of $456.56.

UnitedHealth Group Trading Down 0.3%

NYSE:UNH opened at $393.99 on Friday. The stock has a market capitalization of $353.64 billion, a price-to-earnings ratio of 25.35, a PEG ratio of 1.36 and a beta of 0.62. UnitedHealth Group Incorporated has a 52 week low of $255.96 and a 52 week high of $461.62. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. The firm has a 50 day moving average of $413.28 and a 200 day moving average of $360.11.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, beating the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The firm had revenue of $112.03 billion during the quarter, compared to analyst estimates of $110.81 billion. During the same quarter in the prior year, the business posted $4.08 EPS. The business’s revenue for the quarter was up .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be paid a $2.32 dividend. The ex-dividend date is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a yield of 2.4%. UnitedHealth Group’s dividend payout ratio (DPR) is 59.72%.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 1,169 shares of the business’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.19% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.